112 related articles for article (PubMed ID: 30212401)
1. Docking, synthesis, in-vitro evaluation, and optimization of reaction conditions for direct radiolabeling of CGPRPPC with technetium-99m through the GAGG sequence.
Mosayebnia M; Hajiramezanali M; Shahhosseini S; Hajiagha Bozorgi A; Kobarfard F; Rezaeianpour S
Nucl Med Commun; 2018 Nov; 39(11):976-982. PubMed ID: 30212401
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeling and biological evaluation of the GX1 and RGD-GX1 peptide sequence for angiogenesis targeting.
Oliveira EA; Faintuch BL
Nucl Med Biol; 2015 Feb; 42(2):123-30. PubMed ID: 25311749
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Evaluation of Cyclic [
Rezaeianpour S; Bozorgi AH; Moghimi A; Almasi A; Balalaie S; Ramezanpour S; Nasoohi S; Mazidi SM; Geramifar P; Bitarafan-Rajabi A; Shahhosseini S
Mol Imaging Biol; 2017 Apr; 19(2):256-264. PubMed ID: 27632423
[TBL] [Abstract][Full Text] [Related]
4. Trifluoroacetyl-HYNIC peptides: synthesis and 99mTc radiolabeling.
Surfraz MB; King R; Mather SJ; Biagini SC; Blower PJ
J Med Chem; 2007 Mar; 50(6):1418-22. PubMed ID: 17315986
[TBL] [Abstract][Full Text] [Related]
5.
Vats K; Satpati D; Sharma R; Kumar C; Sarma HD; Dash A
J Labelled Comp Radiopharm; 2017 Jul; 60(9):431-438. PubMed ID: 28545160
[TBL] [Abstract][Full Text] [Related]
6. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
7. Study of the
Kaihani S; Sadeghzadeh N
J Labelled Comp Radiopharm; 2020 Dec; 63(14):582-596. PubMed ID: 32997359
[TBL] [Abstract][Full Text] [Related]
8. Solid-phase synthesis of peptide radiopharmaceuticals using Fmoc-N-epsilon-(hynic-Boc)-lysine, a technetium-binding amino acid: application to Tc-99m-labeled salmon calcitonin.
Greenland WE; Howland K; Hardy J; Fogelman I; Blower PJ
J Med Chem; 2003 Apr; 46(9):1751-7. PubMed ID: 12699393
[TBL] [Abstract][Full Text] [Related]
9. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
Yu F; Lü ML; Zhang XP; Fu D; Hou M; Cai HD; Li D; Wang J; Yuan XY; Lü ZW; Dong F
Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vitro and in vivo properties of [99mTc]cRGD peptides labeled using different novel Tc-cores.
Decristoforo C; Santos I; Pietzsch HJ; Kuenstler JU; Duatti A; Smith CJ; Rey A; Alberto R; Von Guggenberg E; Haubner R
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):33-41. PubMed ID: 17372571
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
[TBL] [Abstract][Full Text] [Related]
12. Chemoselective hydrazone formation between HYNIC-functionalized peptides and (18)F-fluorinated aldehydes.
Bruus-Jensen K; Poethko T; Schottelius M; Hauser A; Schwaiger M; Wester HJ
Nucl Med Biol; 2006 Feb; 33(2):173-83. PubMed ID: 16546671
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of hydrazone formation in HYNIC-peptide conjugate preparation, and its hydrolysis during labeling with (99m)Tc.
Gandomkar M; Najafi R; Shafiei M; Ebrahimi SE
Appl Radiat Isot; 2007 Jul; 65(7):805-8. PubMed ID: 17467277
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeling of annexin A5 with (99m)Tc: comparison of HYNIC-Tc vs. iminothiolane-Tc-tricarbonyl conjugates.
Biechlin ML; Bonmartin A; Gilly FN; Fraysse M; du Moulinet d'Hardemare A
Nucl Med Biol; 2008 Aug; 35(6):679-87. PubMed ID: 18678353
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin(8-13) analogue: radiolabeling and biological evaluation using different chelators.
Teodoro R; Faintuch BL; Núñez EG; Queiróz RG
Nucl Med Biol; 2011 Jan; 38(1):113-20. PubMed ID: 21220134
[TBL] [Abstract][Full Text] [Related]
16. A technetium intermediate specifically promotes deprotection of trifluoroacetyl HYNIC during radiolabelling under mild conditions.
Surfraz MB; Biagini SC; Blower PJ
Dalton Trans; 2008 Jun; (22):2920-2. PubMed ID: 18493625
[TBL] [Abstract][Full Text] [Related]
17. [
Rezaeianpour S; Mosayebnia M; Moghimi A; Amidi S; Geramifar P; Kobarfard F; Shahhosseini S
Cancer Biother Radiopharm; 2018 Dec; 33(10):438-444. PubMed ID: 30234382
[No Abstract] [Full Text] [Related]
18. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
19. Optimized preparation of a (99m)Tc-radiolabeled probe for tracing microRNA.
Kang L; Xu XJ; Ma C; Wang RF; Yan P; Zhang CL; Sun HW; Li D
Cell Biochem Biophys; 2015 Mar; 71(2):905-12. PubMed ID: 25315639
[TBL] [Abstract][Full Text] [Related]
20. Construction of a novel chimera consisting of a chelator-containing Tat peptide conjugated to a morpholino antisense oligomer for technetium-99m labeling and accelerating cellular kinetics.
Zhang YM; Tung CH; He J; Liu N; Yanachkov I; Liu G; Rusckowski M; Vanderheyden JL
Nucl Med Biol; 2006 Feb; 33(2):263-9. PubMed ID: 16546682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
